DIA 48th Annual Meeting
Click here to go to the previous page
Noninterventional Minimal Risk Research: A 360° Perspective
Track : Track 14: Clinical Safety and Pharmacovigilance
Program Code: 256
Date: Tuesday, June 26, 2012
Time: 1:30 PM to 3:00 PM  EST
CHAIR :
 Linda Coleman, Quorum Review IRB, United States
PRESENTER (S):
Kathleen Mandziuk, PRA
 Lindsay Crampton, PPD, United States
 Linda Coleman, Quorum Review IRB, United States
Description
In this interactive session, experts will explore the various types of noninterventional minimal risk studies (including postapproval noninterventional studies, registries, safety-surveillance, and REMS) and their design to ensure compliance with regulatory requirements. The session will also explore the IRB, industry, and site perspective including the value of noninterventional minimal risk studies and models for streamlining the IRB review process.

Learning Objectives:
Describe the agency, IRB, industry, and site perspective regarding studies that qualify as non-interventional minimal risk research
Discuss the various types of noninterventional minimal risk studies.